Qualified expert witness for cooling water and process water treatment disputes in food and beverage manufacturing and pharmaceutical facilities — cooling system failures, Legionella liability, process contamination from water treatment program failure, and regulatory compliance disputes (FDA, USDA, EPA).
Water treatment disputes in food, beverage, and pharmaceutical manufacturing carry a dimension that is absent from most industrial litigation: the potential that a water treatment failure caused a product safety incident, a regulatory action, or a recall. When a water treatment chemical is alleged to have contaminated a food or drug product, or when Legionella at a food facility triggers a regulatory inspection and product hold, the technical analysis requires an expert who understands both industrial cooling water treatment and the regulatory framework governing water quality in food and pharmaceutical manufacturing environments. Jim Green of Industrial Water Advisory brings this combination — senior cooling water expertise informed by the chemical use restrictions, documentation requirements, and contamination pathways specific to food and pharmaceutical manufacturing.
Legionella cases at food and pharmaceutical facilities involve both public health liability — workers and community members at risk — and regulatory exposure, as a Legionella finding can trigger FDA or USDA facility inspection and product hold. Expert analysis addresses water management plan adequacy under ASHRAE 188, biocide program design and execution, monitoring and response protocols, and compliance with applicable state and facility-type-specific requirements.
When a food or pharmaceutical manufacturer alleges that a cooling water treatment chemical contaminated a product batch — through a heat exchanger tube failure, inadvertent cross-connection, or direct contact — expert analysis must address: whether the chemical in question was approved and registered for food or drug manufacturing environments, whether the application was consistent with label requirements, the plausibility of the contamination pathway, and the expected concentration of any residual in the product if the alleged pathway existed.
The Food Safety Modernization Act and current Good Manufacturing Practice regulations impose water quality requirements on food and pharmaceutical manufacturers that intersect with cooling water and process water treatment program obligations. Disputes involving regulatory citations, FDA warning letters, or USDA non-conformances related to water treatment require expert interpretation of both the regulatory requirement and the technical adequacy of the water treatment program.
Fouling of heat exchangers in sterile processing, pasteurization, or CIP (Clean-in-Place) systems in food and pharmaceutical plants raises both efficiency and product safety questions. Expert analysis addresses whether the fouling was caused by inadequate cooling water treatment, whether product safety was compromised by the fouling condition, and whether the treatment vendor's program was appropriate for a food-contact or pharmaceutical-grade heat transfer environment.
When a water treatment service vendor's program failure is alleged to have caused a product recall or triggered regulatory action at a food or pharmaceutical facility, the economic damages — recall costs, destroyed inventory, regulatory response costs, and reputational harm — can be substantial. Expert analysis establishes the causal chain from treatment program deficiency to product safety incident or regulatory violation, and evaluates the vendor's contractual performance obligations.
Corrosion in cooling systems at food and pharmaceutical facilities — particularly where cooling water contacts or could contact product through heat exchanger tube failures — raises product contamination concerns beyond the standard corrosion damage claim. Expert analysis addresses whether the corrosion was attributable to treatment program failure, whether the corrosion products created a foreseeable product contamination risk, and whether the vendor's obligations included corrosion monitoring adequate to detect the failure before product contact occurred.
Confidential discussion of the matter, applicable technical issues, and how industrial cooling water and food/pharmaceutical manufacturing expertise applies to the case. Conflict check and scope discussion. No obligation.
Review of treatment records, water chemistry data, product testing records, regulatory correspondence, vendor service documentation, HACCP plans, and relevant contracts. Site inspection if appropriate. Preliminary opinions rendered.
Written expert report documenting opinions, basis, and methodology to Rule 26 standards. Available for deposition and trial testimony. Opinions are independent and will not be adjusted to favor any party.
Water treatment vendors in food and pharmaceutical disputes frequently argue that their chemical programs were designed correctly and that the contamination claim is not credible. An expert with current affiliation to a major treatment company — or a consulting arrangement with the chemical supplier whose product is at issue — lacks the independence to render a credible contrary opinion.
Industrial Water Advisory carries no current chemical supplier affiliation, no active service contracts with water treatment companies, and no financial interest in the outcome of food or pharmaceutical litigation. Jim Green's former position at Nalco Water provides direct knowledge of how major service companies design food and pharmaceutical programs and define their chemical use obligations — without the conflicts that impair independence.
Initial consultations are confidential. Provide a brief description of the matter — including whether it involves process contamination, Legionella, a product recall, or a regulatory action — and we will respond within one business day to discuss applicability, conflict, and scope.